AMENDMENT TO OFFER LETTEROffer Letter • August 8th, 2017 • Inotek Pharmaceuticals Corp • Pharmaceutical preparations • Massachusetts
Contract Type FiledAugust 8th, 2017 Company Industry JurisdictionThis Amendment to the Offer Letter (this “Amendment”), effective as of August 7, 2017, is made by and between Inotek Pharmaceuticals Corporation, a Delaware corporation (the “Company”), and Rudolf A. Baumgartner, M.D. (“Executive”).